-
Australia
-
Austria
-
Belgium
-
Brazil
-
Canada
-
China
-
Czech Republic
-
Denmark
-
Finland
-
France
-
Germany
-
Greece
-
Hong Kong
-
Hungary
-
Iceland
-
India
-
Ireland
-
Israel
-
Italy
-
Japan
-
Korea
-
Luxembourg
-
Malaysia
-
Netherlands
-
New Zealand
-
Norway
-
Poland
-
Qatar
-
Romania
-
Saudi Arabia
-
Singapore
-
Spain
-
Sweden
-
Switzerland
-
Taiwan
-
Turkey
-
United Kingdom
-
United States
AZD1390 in Glioblastoma and Primary Brain Tumors
Jump to:
- AZD1390 Mechanism of Action: ATM Inhibition in Glioblastoma Cells Research
- AZD1390: Selectivity & Specificity
- AZD1390 Working Concentration | Cell Culture | Treatment
- AZD1390 Solubility in DMSO
- AZD1390 Storage & Stability
- AZD1390 Combination Database
- AZD1390 Molecular Weight | Chemical Structure | Stock Solution
- AZD1390 MedChemExpress (HY-109566)? Try a better option.
- AZD1390 Cayman (36498)? Try a better option.
- AZD1390 Sigma (AMBH303C67A7)? Try a better option.
- AZD1390 Abmole (M9581)? Try a better option.
- AZD1390 SDS｜MSDS
- AZD1390 in Brain Metastases from Solid Tumors
- AZD1390 in Breast Cancer and Solid Tumors
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.